Verastem Oncology
VSTM
#7398
Rank
S$0.68 B
Marketcap
S$7.74
Share price
4.35%
Change (1 day)
18.77%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2026 (TTM): -S$0.25 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are S$49.58 Million. In 2025 the company made an earning of -S$0.28 Billion a decrease over its 2024 earnings that were of -S$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.25 Billion-7.79%
2025 -S$0.28 Billion60.57%
2024 -S$0.17 Billion49.31%
2023 -S$0.12 Billion18.36%
2022 -S$95.28 Million3.67%
2021 -S$91.91 Million5.43%
2020 -S$87.17 Million-54.74%
2019 -S$0.2 Billion105.99%
2018 -S$93.5 Million6.83%
2017 -S$87.52 Million86.06%
2016 -S$47.04 Million-37.03%
2015 -S$74.69 Million8.43%
2014 -S$68.89 Million29.52%
2013 -S$53.19 Million28.6%
2012 -S$41.36 Million133.9%
2011 -S$17.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.67 B-5,560.43%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$1.77 B-809.02%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$12.92 B-5,261.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-S$8.73 Million-96.52%๐Ÿ‡บ๐Ÿ‡ธ USA